NewEdge Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22K	Sell	79 -13	-14%	-$3.74K	﹤0.01%	3166
2025 Q4	$27.9K	Hold	92	–	–	﹤0.01%	3150
2025 Q3	$25.8K	Sell	92 -2	-2%	-$544	﹤0.01%	3038
2025 Q2	$22.7K	Sell	94 -34	-27%	-$8.04K	﹤0.01%	2912
2025 Q1	$31.2K	Sell	128 -34	-21%	-$10.2K	﹤0.01%	2707
2024 Q4	$53.2K	Buy	162 +5	+3%	+$1.7K	﹤0.01%	2506
2024 Q3	$52.5K	Sell	157 -49	-24%	-$15.6K	﹤0.01%	2416
2024 Q2	$56.3K	Sell	206 -325	-61%	-$94.5K	﹤0.01%	2304
2024 Q1	$184K	Sell	531 -155	-23%	-$51K	﹤0.01%	1870
2023 Q4	$222K	Sell	686 -3	-0.4%	-$940	﹤0.01%	1670
2023 Q3	$247K	Sell	689 -2,396	-78%	-$924K	﹤0.01%	1526
2023 Q2	$1.17M	Buy	3,085 +354	+13%	+$144K	0.01%	795
2023 Q1	$1.31M	Buy	2,731 +191	+8%	+$89.4K	0.02%	686
2022 Q4	$73.3K	Buy	+2,540	New	+$1.03M	﹤0.01%	1571
2022 Q1	–	Sell	-272	Closed	-$206K	–	1199
2021 Q4	$206K	Sell	272 -1,341	-83%	-$1M	﹤0.01%	1510
2021 Q3	$1.2M	Buy	+1,613	New	+$1.21M	0.03%	460
2021 Q1	–	Sell	-1,054	Closed	-$614K	–	1034
2020 Q4	$614K	Buy	1,054 +167	+19%	+$95.1K	0.02%	554
2020 Q3	$457K	Buy	+887	New	+$449K	0.02%	605